BOURRIE, BERNARD,CASELLAS, PIERRE,COSNIER-PUCHEU, SYLVIE,JEGHAM, SAMIR,PERREAUT, PIERRE
申请号：
SG11201405566Q
公开号：
SG11201405566QA
申请日:
2013.03.13
申请国别(地区):
SG
年份:
2014
代理人:
摘要：
The present invention relates to combinations of N-[2-(2,1,3-benzothiadiazol-5-ylamino)-6-(2,6-dichlorophenyl) pyrido[2,3-d]pyrimidin-7-yl]-N-(1,1-dimethylethyl)-urea and cytarabine and their use for treating AML or CML.
